Zymeworks (ZYME) stock price, revenue, and financials

Zymeworks market cap is $258.4 m, and annual revenue was $26.68 m in FY 2021

$258.4 M

ZYME Mkt cap, 13-May-2022

$26.7 M

Zymeworks Revenue FY, 2021
Zymeworks Gross profit (FY, 2021)26.7 M
Zymeworks Net income (FY, 2021)-211.8 M
Zymeworks EBITDA (FY, 2021)-206.1 M
Zymeworks EBIT (FY, 2021)-215.5 M
Zymeworks Cash, 31-Dec-2021201.9 M
Zymeworks EV88.8 M
Get notified regarding key financial metrics and revenue changes at ZymeworksLearn more
Banner background

Zymeworks Revenue Breakdown

Embed Graph

Zymeworks revenue breakdown by business segment: 100.0% from CLINICAL-STAGE BIOPHARMACEUTICAL

Zymeworks Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

53.0m29.5m39.0m26.7m

Gross profit

53.0m29.5m39.0m26.7m

R&D expense

(56.9m)(115.9m)(168.5m)(199.8m)

Operating expense total

(82.8m)(174.7m)(216.1m)(232.7m)

Depreciation and amortization

(3.6m)(5.4m)(10.3m)(9.6m)

EBITDA

(29.7m)(145.1m)(177.2m)(206.0m)

EBIT

(37.1m)(150.7m)(187.5m)(215.5m)

Interest income

2.6m6.0m5.7m2.0m

Pre tax profit

(34.4m)(146.0m)(180.1m)(212.4m)

Income tax expense

(2.2m)582.0k(429.0k)516.0k

Net Income

(36.6m)(145.4m)(180.6m)(211.8m)

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

11.9m7.9m7.9m8.3m12.4m2.6m644.0k1.8m4.4m

Gross profit

11.9m7.9m7.9m8.3m12.4m2.6m836.0k1.7m4.4m

R&D expense

(17.5m)(23.8m)(29.3m)(36.5m)(39.2m)(53.5m)(44.3m)(50.7m)(49.9m)

Operating expense total

(25.0m)(35.0m)(39.7m)(41.3m)(50.4m)(73.7m)(43.0m)(67.9m)(62.6m)

Depreciation and amortization

(1.5m)(1.6m)(1.7m)(2.8m)(2.3m)(2.7m)(2.6m)(2.8m)(2.8m)

EBITDA

(13.1m)(27.1m)(31.9m)(33.0m)(38.1m)(71.0m)(42.1m)(66.2m)(58.2m)

EBIT

(14.6m)(28.7m)(33.6m)(35.9m)(40.3m)(73.7m)(44.7m)(69.0m)(61.0m)

Interest expense

(18.0k)(52.0k)(20.0k)(38.0k)

Interest income

1.3m1.2m2.1m1.9m1.5m1.3m741.0k588.0k340.0k

Pre tax profit

(13.4m)(28.4m)(31.4m)(30.8m)(39.0m)(72.6m)(44.1m)(68.0m)(59.8m)

Income tax expense

(193.0k)(635.0k)908.0k(375.0k)64.0k43.0k(525.0k)434.0k(764.0k)

Net Income

(13.6m)(29.1m)(30.5m)(31.1m)(39.0m)(72.6m)(44.6m)(67.5m)(60.6m)

Zymeworks Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

42.2m128.5m242.0m201.9m

Accounts Receivable

358.0k2.2m15.3m15.6m

Prepaid Expenses

3.8m10.7m13.4m20.0m

Current Assets

204.4m311.8m455.1m288.2m

PP&E

6.5m11.1m12.2m22.8m

Goodwill

12.0m12.0m12.0m12.0m

Total Assets

244.5m368.2m538.4m389.1m

Accounts Payable

2.6m5.3m6.2m5.2m

Short-term debt

1.3m2.7m1.3m

Current Liabilities

30.0m82.6m85.7m71.9m

Long-term debt

239.0k5.6m5.9m31.0m

Non-Current Liabilities

34.0m40.0m42.8m68.2m

Total Debt

239.0k6.9m8.6m32.3m

Total Liabilities

64.0m122.5m128.5m140.0m

Common Stock

320.1m450.2m724.2m741.1m

Additional Paid-in Capital

12.3m92.8m163.6m197.7m

Retained Earnings

(145.3m)(290.7m)(471.3m)(683.1m)

Total Equity

180.5m245.7m409.9m249.1m

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

43.2m283.5m250.8m189.5m219.6m244.1m279.9m257.2m253.4m

Accounts Receivable

703.0k2.7m3.3m8.7m14.8m3.7m4.6m9.2m4.9m

Prepaid Expenses

9.0m8.0m6.8m8.3m19.7m11.8m16.7m24.0m24.1m

Current Assets

190.3m366.4m345.3m504.6m471.3m487.3m432.8m393.0m336.8m

PP&E

13.9m15.7m15.6m11.0m12.5m12.5m12.3m14.0m18.6m

Goodwill

12.0m12.0m12.0m12.0m12.0m12.0m12.0m12.0m12.0m

Total Assets

238.3m414.5m400.0m636.6m606.9m571.7m490.1m472.0m420.4m

Accounts Payable

1.4m4.1m8.0m12.5m4.7m3.1m4.9m4.7m5.0m

Short-term debt

1.7m1.7m921.0k1.7m1.9m1.9m3.0m1.6m1.3m

Current Liabilities

28.2m40.4m50.7m72.9m72.8m96.9m70.2m83.0m75.4m

Long-term debt

6.4m6.2m5.9m7.3m6.7m6.0m5.4m30.2m28.7m

Non-Current Liabilities

40.1m40.1m39.8m41.3m42.8m42.5m42.7m67.5m66.0m

Total Debt

8.1m7.9m6.8m9.1m8.6m7.9m8.4m31.8m30.1m

Total Liabilities

68.3m80.5m90.5m114.2m115.6m139.4m112.9m150.5m141.4m

Common Stock

320.9m441.2m444.4m707.6m708.3m715.3m729.0m730.3m739.6m

Additional Paid-in Capital

14.6m87.5m90.2m143.3m150.4m157.1m170.6m181.2m190.0m

Retained Earnings

(158.9m)(188.0m)(218.5m)(321.8m)(360.8m)(433.4m)(515.9m)(583.4m)(644.0m)

Total Equity

170.0m334.0m309.5m522.4m491.3m432.4m377.1m321.5m278.9m

Zymeworks Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

(36.6m)(145.4m)(180.6m)(211.8m)

Depreciation and Amortization

3.6m5.4m7.5m6.5m

Accounts Receivable

(119.0k)(1.8m)(13.1m)(266.0k)

Accounts Payable

3.7m21.6m7.6m16.5m

Cash From Operating Activities

24.2m(81.9m)(151.4m)(192.5m)

Cash From Investing Activities

(109.0m)(25.6m)(43.4m)144.6m

Long-term Borrowings

(11.0k)(16.0k)

Cash From Financing Activities

91.4m193.7m309.0m8.0m

Net Change in Cash

6.3m86.2m113.6m(40.2m)

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

(13.6m)(42.7m)(73.2m)(31.1m)(70.1m)(142.7m)(44.6m)(112.1m)(172.7m)

Depreciation and Amortization

1.5m3.1m4.7m1.8m3.5m5.5m2.0m4.1m5.5m

Accounts Receivable

320.0k(1.4m)(2.1m)(6.5m)(12.6m)(1.5m)10.7m6.1m10.4m

Accounts Payable

(2.4m)2.8m12.4m1.1m(1.8m)15.1m(163.0k)10.3m10.7m

Cash From Operating Activities

(21.3m)(34.6m)(45.5m)(37.5m)(87.4m)(103.5m)(40.8m)(91.2m)(141.9m)

Cash From Investing Activities

22.0m85.4m62.6m(204.8m)(124.4m)(86.8m)76.8m104.1m146.5m

Long-term Borrowings

(8.0k)(11.0k)(13.0k)

Cash From Financing Activities

569.0k190.5m191.5m302.8m303.0m306.3m2.1m2.8m7.3m

Net Change in Cash

969.0k241.3m208.6m61.0m91.1m115.7m37.9m15.1m11.4m

Zymeworks Ratios

USDFY, 2018

Zymeworks Employee Rating

3.253 votes
Culture & Values
4.7
Work/Life Balance
4.2
Senior Management
4.2
Salary & Benefits
4.2
Career Opportunities
4.2
Source